Forty-eight subjects were enrolled in the study and 24 subjects (16 females, 8 males) were randomised to each of the 2.5 and 5mg groups (figure 1). There were no discontinuations during the study.
Additional Focus Groups Corroborate UltraShear Nano-THC Produces Equal to Much Better THC Experiences, Even from Lower THC Dosing Levels; Also, Lightning-Fast Pain Relief from Topical Use. SOUTH ...
ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections Melbourne, Australia, 29 January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results